BotaniX was founded in 2017 with a clear conviction: the botanical ingredients industry was broken. Supply chains stretched across continents offered little transparency, quality varied unpredictably from batch to batch, and the most promising parts of medicinal plants, particularly the roots, were simply inaccessible through conventional cultivation.

We set out to change that. Starting from a 1,000 sqm R&D and production facility in Ile-de-France, our team of pharmacists, plant biologists, and engineers developed a proprietary aeroponic cultivation platform that gives us full control over every growth parameter, from light spectrum and nutrient delivery to abiotic stress protocols that enhance active compound production.

What began as an indoor cultivation project quickly evolved into something more ambitious. As we mastered the science of growing medicinal plants with pharmaceutical-grade precision, we discovered that our controlled-environment approach unlocked molecules that traditional supply chains could never reliably deliver. Today, BotaniX serves leading multinational brands in cosmetics, nutraceuticals, and health, providing them with traceable, potent, and consistent botanical actives produced entirely in Europe.

Our journey continues. Beyond our established ingredient marketplace, our R&D programs are exploring plant-derived delivery technologies and AI-guided discovery of novel bioactive compounds, positioning BotaniX at the frontier of botanical deeptech innovation.